A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine | MicrobiomeTrials← Back to trialsNCT07719608
A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-12-01Est. Completion: 2028-10-01
Enrollment target: 150 participants Locations- Vista Clinical Research, Newnan, Georgia, United States
- MedStar Health Research Institute, Olney, Maryland, United States
- Queen City Clinical Research, PLLC, Charlotte, North Carolina, United States
Other microbiome trials you might be interested in
Chronic Migraine Headache
To evaluate the effectiveness and safety of middle meningeal artery (MMA) embolization using non-adhesive materials SQUI…
Bishkek, KyrgyzstanCompleted Apr 2028
Headache, MigraineChronic Migraine Headache
Stellate Ganglion Block (SGB) is an interventional anesthetic technique used to treat pain conditions affecting the head…
Ankara, Turkey (Türkiye)Completed Dec 30, 2025
Chronic Low Back PainMusculoskeletal Pain
The objectives of this VA Merit application are to demonstrate efficacy of combined intermittent theta burst (iTBS) and …
Chicago, United StatesEst. completion Jun 1, 2031